Shares of Merck & Co. Inc. MRK sank 0.60% to $99.25 Friday, on what proved to be an all-around rough trading session for the ...

We recently published a list of Jim Cramer Discussed These 29 Stocks Ahead Of Major AI Event. In this article, we are going ...

CG Oncology's stock has dropped 40% since its IPO peak, driven by profit-taking and competitive concerns despite promising ...

Merck & Co Inc (MRK) stock saw a decline, ending the day at $99.85 which represents a decrease of $-1.17 or -1.16% from the prior close of $101.02. The stock opened at $100.7 and touched a low of $98.

With a market cap of $252.6 billion, Rahway, New Jersey-based Merck & Co., Inc. (MRK) is a global leader in the healthcare ...

Pfizer's experimental treatment for a type of bladder cancer significantly improved the time that patients remained free of ...

Drugmakers have greeted 2025, implementing price hikes for 583 products within the first two days of the new year, according ...

Bernstein analyst Courtney Breen maintained a Hold rating on Merck & Company (MRK – Research Report) today and set a price target of ...

As a wave of volatility has been re-introduced to the system, investors are flocking toward blue-chip companies for stability ...

Fintel reports that on January 8, 2025, Truist Securities downgraded their outlook for Merck (NYSE:MRK) from Buy to Hold.

Merck's human papillomavirus vaccine has been approved for men in China, it said on Wednesday, providing the U.S. drugmaker a ...

Merck just rewarded its shareholders again with a dividend hike. This Dow stock has come with a quarterly dividend for almost ...